Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1622 1625
This examiner grants 81% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18569571 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | Non-Final OA | LG CHEM, LTD. |
| 18569568 | PHARMACEUTICAL COMPOSITION COMPRISING 1-(3-CYANO-1-ISOPROPYL-INDOL-5-YL)PYRAZOLE-4-CARBOXYLIC ACID | Non-Final OA | LG CHEM, LTD. |
| 18452008 | PHARMACEUTICAL PROCESS AND INTERMEDIATES | Non-Final OA | ASTRAZENECA AB |
| 18551614 | PROCESS FOR PREPARING (2Z)-2-(PHENYLIMINO)-1,3-THIAZOLIDINE-4-ONE-SULFOXIDE DERIVATIVES IN AN ENANTIOMERICALLY ENRICHED FORM | Non-Final OA | Bayer Aktiengesellschaft |
| 18247795 | METHOD FOR PRODUCING CARBONYLAMINOFURANS | Non-Final OA | Bayer Aktiengesellschaft |
| 18751865 | METHOD OF TREATMENT | Non-Final OA | Vanda Pharmaceuticals Inc. |
| 17771241 | NOVEL SUBSTITUTED CONDENSED RING COMPOUND | Non-Final OA | Sumitomo Pharma Co., Ltd. |
| 18563284 | NOVEL AZAINDOLE DERIVATIVES AS ANTIVIRAL AGENTS | Non-Final OA | Université de Montpellier |
| 18254320 | PRODUCT OF INTERNAL DEHYDRATION OF HIGH-PURITY SORBITOL | Non-Final OA | ROQUETTE FRERES |
| 18571860 | SULFONAMIDE OREXIN RECEPTOR AGONISTS AND USES THEREOF | Non-Final OA | Jazz Pharmaceuticals Ireland Limited |
| 18566134 | EYE DROP COMPOSITION FOR PREVENTION OR TREATMENT OF OPHTHALMIC DISEASES AND PREPARATION METHOD THEREFOR | Non-Final OA | OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. |
| 18279103 | Methods of Reducing Risk of Prostate Cancer Progression | Non-Final OA | Astellas Pharma Inc. |
| 18288338 | CERTAIN N-(1-CYANO-2-PHENYLETHYL)-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING CYSTIC FIBROSIS | Non-Final OA | Insmed Incorporated |
| 18555567 | EASY CHEW FORMULATIONS | Non-Final OA | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| 18283158 | VACCINE ADJUVANT | Non-Final OA | Celleron Therapeutics Limited |
| 18004806 | GLUCOCORTICOID-SPARING AGENT | Non-Final OA | METRIOPHARM AG |
| 18058441 | SYNTHESIS OF HALICHONDRINS | Non-Final OA | Eisai R&D Management Co., LTD. |
| 17974443 | N-N-DIMETHYLTRYPTAMINE (DMT) AND DMT ANALOG COMPOSITIONS, METHODS OF MAKING, AND METHODS OF USE THEREOF | Final Rejection | ATAI Life Sciences AG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy